Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: A nationwide claims‐based investigation
Open Access
Abstract
BACKGROUND: Women have disproportionately higher mortality rates relative to incidence for bladder cancer. Multiple etiologies have been proposed, including delayed diagnosis and treatment. Guidelines recommend ruling out malignancy in men and women presenting with hematuria. This study sought to determine the difference in timing from presentation with hematuria to diagnosis of bladder cancer in women versus men.METHODS: This is a retrospective population‐based study examining the timing from presentation with hematuria to diagnosis of bladder cancer, based on data from the MarketScan databases, which include enrollees of more than 100 health insurance plans of approximately 40 large US employers from 2004 through 2010. All study patients presented with hematuria and were subsequently diagnosed with bladder cancer. The primary outcome measure was number of days between initial presentation with hematuria and diagnosis of bladder cancer by sex.RESULTS: A total of 5416 men and 2233 women met inclusion criteria. Mean days from initial hematuria claim to bladder cancer claim was significantly longer in women (85.4 versus 73.6 days, P < .001), and the proportion of women with >6 month delay in bladder cancer diagnosis was significantly higher (17.3% versus 14.1%, P < .001). Women were more likely to be diagnosed with urinary tract infection (odds ratio = 2.32, 95% confidence interval = 2.07‐2.59) and less likely to undergo abdominal or pelvic imaging (odds ratio = 0.80, 95% confidence interval = 0.71‐0.89).CONCLUSIONS: Both men and women experience significant delays between presentation with hematuria and diagnosis of bladder cancer, with longer delays for women. This may be partly responsible for the sex‐based discrepancy in outcomes associated with bladder cancer. Cancer 2014;120:555–661. © 2013 American Cancer Society.Keywords
Funding Information
- Institut National de la Santé et de la Recherche Médicale (UL1 TR000430)
This publication has 32 references indexed in Scilit:
- Gender inequalities in the promptness of diagnosis of bladder and renal cancer after symptomatic presentation: evidence from secondary analysis of an English primary care audit surveyBMJ Open, 2013
- Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer?BJU International, 2013
- Cancer treatment and survivorship statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- Delays in diagnosis and bladder cancer mortalityCancer, 2010
- Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for EnglandThe Lancet Oncology, 2009
- Mortality increases when radical cystectomy is delayed more than 12 weeksCancer, 2009
- Factors Influencing Aggressive Therapy for Bladder Cancer: An Analysis of Data From the SEER ProgramJournal of Urology, 2003
- Delaying Radical Cystectomy for Muscle Invasive Bladder Cancer Results in Worse Pathological StageJournal of Urology, 2003
- The prognostic role of gender in survival of adult cancer patientsEuropean Journal of Cancer, 1998
- Microscopic haematuria: urological investigation using a standard protocolBritish Journal of Urology, 1996